{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T22:10:41Z","timestamp":1767910241057,"version":"3.49.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2010,5,13]],"date-time":"2010-05-13T00:00:00Z","timestamp":1273708800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s10072-010-0319-0","type":"journal-article","created":{"date-parts":[[2010,5,12]],"date-time":"2010-05-12T12:05:19Z","timestamp":1273665919000},"page":"175-177","source":"Crossref","is-referenced-by-count":16,"title":["The efficacy of withdrawal therapy in subjects with chronic daily headache and medication overuse following prophylaxis with topiramate and amitriptyline"],"prefix":"10.1007","volume":"31","author":[{"given":"Fabio","family":"Valguarnera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Tanganelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,13]]},"reference":[{"key":"319_CR1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(04)00824-5","volume":"3","author":"HC Diener","year":"2004","unstructured":"Diener HC, Limmroth V (2004) Medication overuse headache: a worldwide problem. Lancet Neurol 3:475\u2013483","journal-title":"Lancet Neurol"},{"key":"319_CR2","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1046\/j.1526-4610.1999.3903190.x","volume":"39","author":"J Castillo","year":"1999","unstructured":"Castillo J, Munoz P, Guitera V, Pascual J (1999) Epidemiology of chronic daily headache in the general population. Headache 39:190\u2013196","journal-title":"Headache"},{"key":"319_CR3","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1526-4610.2009.01432.x","volume":"49","author":"A Manack","year":"2009","unstructured":"Manack A, Turkel C, Silberstein S (2009) The evolution of chronic migraine: classification a nomenclature. Headache 49:1206\u20131213","journal-title":"Headache"},{"issue":"Suppl 1","key":"319_CR4","first-page":"9","volume":"24","author":"Headache Classification Subcommittee of the International Headache Society","year":"2004","unstructured":"Headache Classification Subcommittee of the International Headache Society (2004) The international classification of headache disorders: 2nd edition. Cephalalgia 24(Suppl 1):9\u2013160","journal-title":"Cephalalgia"},{"key":"319_CR5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1468-2982.2005.00879.x","volume":"25","author":"JR Saper","year":"2005","unstructured":"Saper JR, Hamel RL, Lake AE III (2005) Medication overuse headache (MOH) is a behavioural disorder. Cephalalgia 25:545\u2013546","journal-title":"Cephalalgia"},{"key":"319_CR6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1526-4610.2005.05068.x","volume":"45","author":"DW Dodick","year":"2005","unstructured":"Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD (2005) Botulinum toxin type A for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Headache 45:315\u2013324","journal-title":"Headache"},{"key":"319_CR7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1526-4610.2005.05066.x","volume":"45","author":"NT Mathew","year":"2005","unstructured":"Mathew NT, Frishberg BM, Gawel M, Dimitrova R, Gibson J, Turkel C (2005) Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized double-blind, placebo-controlled trial. Headache 45:293\u2013307","journal-title":"Headache"},{"key":"319_CR8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11916-006-0012-4","volume":"10","author":"L Grazzi","year":"2006","unstructured":"Grazzi L, Andrasik F (2006) Medication overuse headache: description, treatment and relapse prevention. Curr Pain Headache Rep 10:71\u201377","journal-title":"Curr Pain Headache Rep"},{"key":"319_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1526-4610.1994.hed3401001.x","volume":"34","author":"SD Silberstein","year":"1994","unstructured":"Silberstein SD, Lipton RB, Solomon S, Mathew NT (1994) Classification of daily and near daily headaches: proposed revisions to the IHS classification. Headache 34:1\u20137","journal-title":"Headache"},{"key":"319_CR10","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1468-2982.2007.01326.x","volume":"27","author":"HC Dierer","year":"2007","unstructured":"Dierer HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ (2007) Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 27:814\u2013823","journal-title":"Cephalalgia"},{"key":"319_CR11","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.1526-4610.2002.02183.x","volume":"42","author":"NT Mathew","year":"2002","unstructured":"Mathew NT, Kailasam J, Meadors L (2002) Prophylaxis of migraine, transformed migraine and cluster headache with topiramate. Headache 42:796\u2013803","journal-title":"Headache"},{"key":"319_CR12","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archneur.1987.00520170016015","volume":"44","author":"DK Ziegler","year":"1987","unstructured":"Ziegler DK, Hurwitz A, Hassaneim RS, Kodanaz HA, Preskom SH, Mason J (1987) Migraine prophylaxis: a comparison of propranolol and amitriptyline. Arch Neurol 44:486\u2013489","journal-title":"Arch Neurol"},{"key":"319_CR13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1526-4610.1981.hed2103105.x","volume":"21","author":"NT Mathew","year":"1981","unstructured":"Mathew NT (1981) Prophylaxis of migraine and mixed headache: a randomized controlled study. Headache 21:105\u2013109","journal-title":"Headache"},{"key":"319_CR14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/archneur.1979.00500470065013","volume":"36","author":"JR Couch","year":"1979","unstructured":"Couch JR, Hassaneim RS (1979) Amitriptyline in migraine prophylaxis. Arch Neurol 36:695\u2013699","journal-title":"Arch Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-010-0319-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-010-0319-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-010-0319-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T09:11:45Z","timestamp":1559121105000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-010-0319-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,13]]},"references-count":14,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["319"],"URL":"https:\/\/doi.org\/10.1007\/s10072-010-0319-0","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,13]]}}}